Synflorix™ (10-valent pneumococcal conjugate vaccine; GlaxoSmithKline Biologicals, Belgium) has been investigated globally to evaluate immunogenicity, safety and reactogenicity with different ...

This application is seeking the use of Synflorix as a paediatric pneumococcal vaccine, for the active immunisation against pneumonia caused by Streptoccuss pneumoniae in infants and children aged ...